Annovis Bio, Inc.
Annovis Bio, Inc. is a late-stage clinical drug platform company developing novel therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
/10
Transparency ranking
Work at Annovis Bio, Inc.?
Tell us what we're missing about working at Annovis Bio, Inc. so we can make the job search more transparent for everyone.
Tell us what it's like to work at Annovis Bio, Inc.!Description
Annovis Bio, Inc. is a clinical-stage drug platform company focused on developing novel therapies for neurodegenerative diseases, specifically Alzheimer's disease (AD) and Parkinson's disease (PD). Their lead drug candidate, buntanetap, targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, aiming to improve synaptic transmission, axonal transport, and reduce neuroinflammation. Buntanetap is an orally available small molecule, making it a potential game-changer for patients who struggle with the side effects or inconvenient administration of other treatments.
Annovis Bio is driven by a mission to halt the death of nerve cells and present new hope for millions of patients and their families. They are actively engaged in clinical trials for both AD and PD and have recently made significant progress with their Phase III Parkinson's study and Phase II/III Alzheimer's study, with data expected in the near future.
Mission
Annovis Bio is a company dedicated to developing transformative therapies for neurodegenerative diseases, specifically Alzheimer's Disease and Parkinson's Disease. Their mission is to stop the death of nerve cells by developing scientifically proven treatments that restore brain function and improve the quality of life for patients. This goal is driven by a desire to provide hope and resilience to the millions of people affected by these debilitating conditions and their families.
Culture
Annovis Bio promotes a culture of innovation, collaboration, and dedication to finding effective treatments for neurodegenerative diseases. The company emphasizes a people-focused approach, driven by passion and a clear purpose to bring hope and meaningful change to patients and their families. This commitment to patient care is evident in their dedication to research, development, and clinical trials, while their commitment to transparency and open communication fosters a collaborative environment where team members work together to achieve their shared goals.
DE&I
Annovis Bio does not explicitly discuss its approach to diversity, equity, and inclusion (DE&I) on its website.
Similar companies. But verified.
